Mepolizumab
ATC R03DX09 · 10 markets · 28 records
AU 6 records · 3 strengths
- 100 mginjectionNUCALA mepolizumab 100 mg powder forNUCALA mepolizumab 100 mg solution for injection in pre-filled pen、NUCALA mepolizumab 100 mg solution for injection in pre-filled syringe
- 100 mg/1 mLinjectionNucala
Records without a stated strength · 1 Nucala
GB 4 records · 3 strengths
- 100 mginjectionNucala 100mg powder for solution for injection vials
- 100 mg/1 mLinjectionNucala 100mg/1ml solution for injection pre-filled pensNucala 100mg/1ml solution for injection pre-filled syringes
- 40 mg/0.4 mLinjectionNucala 100mg/1ml solution for injection pre-filled syringes
US 3 records · 2 strengths
CA 3 records · 2 strengths
ES 3 records · 2 strengths
- 100 mginjectionNUCALA PRECARGADA
- 40 mginjectionNUCALA PRECARGADA
SG 2 records · 2 strengths
- 40 mg/0.4 mLinjectionNUCALA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 40MG/0.4ML
- 100 mg/mLinjectionNUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML
TW 2 records · 2 strengths
- 100 mginjectionNucala Solution for Injection 100mg/mL舒肺樂注射劑100毫克/毫升
Records without a stated strength · 1 Nucala Powder for Solution for Injection、舒肺樂凍晶注射劑
HK 1 records · 1 strengths
Records without a stated strength · 1 NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/1ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Nucala
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 100 mg injection | Nucala | Nucala 100mg powder for solution for injection vials | NUCALA mepolizumab 100 mg powder for NUCALA mepolizumab 100 mg solution for injection in pre-filled pen NUCALA mepolizumab 100 mg solution for injection in pre-filled syringe | NUCALA PRECARGADA | Nucala Solution for Injection 100mg/mL 舒肺樂注射劑100毫克/毫升 | ||||
| 100 mg/1 mL injection | Nucala 100mg/1ml solution for injection pre-filled pens Nucala 100mg/1ml solution for injection pre-filled syringes | Nucala | |||||||
| 40 mg/0.4 mL injection | Nucala | Nucala 100mg/1ml solution for injection pre-filled syringes | NUCALA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 40MG/0.4ML | ||||||
| 100 mg liquid | Nucala | ||||||||
| 40 mg liquid | Nucala | ||||||||
| 100 mg/mL injection | NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/ML | ||||||||
| 40 mg injection | NUCALA PRECARGADA | ||||||||
unknown | Nucala | NUCALA SOLUTION FOR INJECTION IN PRE-FILLED PEN 100MG/1ML | Nucala | ||||||
injection | Nucala Powder for Solution for 舒肺樂凍晶注射劑 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
5 more strength/form rows are recorded only in CA · SG · ES · TW and are not shown in this table. Hay 5 filas de concentración/forma registradas solo en CA · SG · ES · TW que no se muestran en esta tabla. 另有 5 个规格/剂型仅在 CA · SG · ES · TW 有记录(未在本表显示)。 另有 5 個規格/劑型僅在 CA · SG · ES · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.